image
Basic Materials - Chemicals - Specialty - NASDAQ - US
$ 156.01
-2.35 %
$ 5.09 B
Market Cap
37.41
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one BCPC stock under the worst case scenario is HIDDEN Compared to the current market price of 156 USD, Balchem Corporation is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one BCPC stock under the base case scenario is HIDDEN Compared to the current market price of 156 USD, Balchem Corporation is HIDDEN

This DCF valuation model was last updated on Jun, 21, 2025.

The intrinsic value of one BCPC stock under the best case scenario is HIDDEN Compared to the current market price of 156 USD, Balchem Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart BCPC

image
$180.0$180.0$175.0$175.0$170.0$170.0$165.0$165.0$160.0$160.0$155.0$155.0$150.0$150.0Jan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 Jun
FINANCIALS
954 M REVENUE
3.39%
183 M OPERATING INCOME
14.90%
128 M NET INCOME
18.36%
182 M OPERATING CASH FLOW
-0.96%
-59.7 M INVESTING CASH FLOW
-71.59%
-134 M FINANCING CASH FLOW
12.72%
251 M REVENUE
4.38%
51 M OPERATING INCOME
7.53%
37.1 M NET INCOME
10.33%
36.5 M OPERATING CASH FLOW
-30.32%
-5.91 M INVESTING CASH FLOW
84.00%
-32 M FINANCING CASH FLOW
9.21%
Balance Sheet Balchem Corporation
image
Current Assets 314 M
Cash & Short-Term Investments 49.5 M
Receivables 120 M
Other Current Assets 145 M
Non-Current Assets 1.26 B
Long-Term Investments 0
PP&E 299 M
Other Non-Current Assets 962 M
3.14 %7.60 %9.18 %18.99 %61.09 %Total Assets$1.6b
Current Liabilities 158 M
Accounts Payable 54.7 M
Short-Term Debt 3.33 M
Other Current Liabilities 99.6 M
Non-Current Liabilities 268 M
Long-Term Debt 205 M
Other Non-Current Liabilities 63.1 M
12.87 %23.41 %48.12 %14.82 %Total Liabilities$425.5m
EFFICIENCY
Earnings Waterfall Balchem Corporation
image
Revenue 954 M
Cost Of Revenue 617 M
Gross Profit 336 M
Operating Expenses 153 M
Operating Income 183 M
Other Expenses 54.4 M
Net Income 128 M
1b1b900m900m800m800m700m700m600m600m500m500m400m400m300m300m200m200m100m100m00954m(617m)336m(153m)183m(54m)128mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
35.25% GROSS MARGIN
35.25%
19.18% OPERATING MARGIN
19.18%
13.47% NET MARGIN
13.47%
11.17% ROE
11.17%
8.16% ROA
8.16%
9.93% ROIC
9.93%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Balchem Corporation
image
160m160m140m140m120m120m100m100m80m80m60m60m40m40m20m20m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 128 M
Depreciation & Amortization 48 M
Capital Expenditures -35.7 M
Stock-Based Compensation 16.7 M
Change in Working Capital -6.12 M
Others -9.93 M
Free Cash Flow 146 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Balchem Corporation
image
Wall Street analysts predict an average 1-year price target for BCPC of $178 , with forecasts ranging from a low of $152 to a high of $190 .
BCPC Lowest Price Target Wall Street Target
152 USD -2.57%
BCPC Average Price Target Wall Street Target
178 USD 14.35%
BCPC Highest Price Target Wall Street Target
190 USD 21.79%
Price
Max Price Target
Min Price Target
Average Price Target
190190185185180180175175170170165165160160155155150150Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
4. DIVIDEND ANALYSIS
0.52% DIVIDEND YIELD
0.87 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
0.900.900.800.800.700.700.600.600.500.500.400.400.300.300.200.200.100.100.000.000.340.340.380.380.420.420.470.470.520.520.580.580.640.640.710.710.790.790.870.8720152015201620162017201720182018201920192020202020212021202220222023202320242024
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 9
6. Ownership
Insider Ownership Balchem Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
2.25 M USD 2
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Balchem Corporation to Present at the Wells Fargo Industrials and Materials Conference on June 11, 2025 MONTVALE, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wells Fargo Industrials and Materials Conference on June 11, 2025. globenewswire.com - 3 weeks ago
Balchem Corporation to Participate in the dbAccess Global Consumer Conference on June 4, 2025 MONTVALE, N.J., May 21, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the dbAccess Global Consumer Conference on June 4, 2025. globenewswire.com - 1 month ago
Balchem Corporation (BCPC) Q1 2025 Earnings Call Transcript Balchem Corporation (NASDAQ:BCPC ) Q1 2025 Earnings Conference Call April 24, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President & CEO Conference Call Participants Ram Selvaraju - H.C. Wainwright & Co Daniel Harriman - Sidoti & Company Operator Greetings, and welcome to Balchem's First Quarter 2025 Earnings Conference Call. seekingalpha.com - 1 month ago
Blachem (BCPC) Lags Q1 Earnings Estimates Blachem (BCPC) came out with quarterly earnings of $1.22 per share, missing the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.89 per share a year ago. zacks.com - 1 month ago
Blachem (BCPC) Upgraded to Strong Buy: Here's Why Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). zacks.com - 2 months ago
Balchem Corporation Announces Quarterly Conference Call for First Quarter 2025 Financial Results on April 24, 2025 MONTVALE, N.J., April 11, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, April 24, 2025, at 11:00 AM Eastern Time (ET) to review first quarter 2025 results. globenewswire.com - 2 months ago
Balchem Corporation to Participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025 MONTVALE, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025. globenewswire.com - 3 months ago
Balchem Is A Great Company, But I'm Still Waiting For A Better Entry Balchem Corporation specializes in performance ingredients across nutrition, food, pharmaceuticals, and animal health, but its high P/E ratio and rising costs warrant a "Hold" rating. Q4 2024 saw modest revenue growth of 4.9%, with notable gains in GAAP earnings (23.8%) and adjusted EBITDA (13.4%), driven by strong Human Nutrition & Health performance. Despite growth in key segments, Balchem's high valuation and macroeconomic pressures suggest waiting for a more attractive entry point for new investors. seekingalpha.com - 3 months ago
Balchem Corporation (BCPC) Q4 2024 Earnings Conference Call Transcript Balchem Corporation (NASDAQ:BCPC ) Q4 2024 Earnings Conference Call February 21, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President and CEO Conference Call Participants Bob Labick - CJS Securities Ram Selvaraju - H.C. Wainwright & Co Daniel Harriman - Sidoti & Company Operator Greetings, and welcome to Balchem's Fourth Quarter and Full Year 2024 Earnings Call. seekingalpha.com - 4 months ago
Blachem (BCPC) Lags Q4 Earnings and Revenue Estimates Blachem (BCPC) came out with quarterly earnings of $1.03 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.82 per share a year ago. zacks.com - 4 months ago
Balchem Corporation Reports Fourth Quarter and Full Year 2024 Financial Results MONTVALE, N.J., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal fourth quarter ended December 31, 2024. globenewswire.com - 4 months ago
Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter and Full Year 2024 Financial Results on February 21, 2025 MONTVALE, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, February 21, 2025, at 11:00 AM Eastern Time (ET) to review fourth quarter and full year 2024 results. globenewswire.com - 4 months ago
8. Profile Summary

Balchem Corporation BCPC

image
COUNTRY US
INDUSTRY Chemicals - Specialty
MARKET CAP $ 5.09 B
Dividend Yield 0.52%
Description Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
Contact 52 Sunrise Park Road, Montvale, NY, 10958 https://www.balchem.com
IPO Date June 3, 1986
Employees 1379
Officers Mr. Jonathan H. Griffin Senior Vice President of Corporate Development Mr. M. Brent Tignor Senior Vice President & Chief Human Resources Officer Mr. Theodore Lee Harris Chief Executive Officer, President & Chairman Mr. Carl Martin Bengtsson Executive Vice President, Chief Financial Officer, Treasurer and GM of Animal Nutrition & Health Ms. Hatsuki Miyata J.D. Executive Vice President, Chief Legal Officer & Secretary Mr. Job L. van Gunsteren Senior Vice President & GM of Specialty Products Mr. Frederic Boned Senior Vice President and GM of Human Nutrition & Health Mr. Martin Luther Reid Senior Vice President & Chief Supply Chain Officer Mr. William A. Backus CPA Vice President & Chief Accounting Officer